Development of Outcome Metrics Leads to First FDA-Approved Treatment for Eosinophilic Esophagitis Dakota Campbell Mon, 06/27/2022 - 11:31
CEGIR members gathering in 2020

For the first time, patients diagnosed with eosinophilic esophagitis (EoE) have a treatment option approved by the US Food and Drug Administration (FDA). Years of clinical trials led to the official approval of Dupixent (dupilumab) on May 20, 2022. To begin these clinical trials, researchers first had to answer a question—how do we evaluate the effectiveness of a treatment for EoE? A collaborative team of patients, advocates, researchers, and clinicians from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) worked to identify outcome metrics to make these clinical trials possible. 

Early Stage Investigator Spotlight: Girish Hiremath Explores the Epidemiology of Eosinophilic Gastrointestinal Diseases Dakota Campbell Fri, 03/04/2022 - 10:33
Headshot of Girish Hiremath, MD, MPH

Girish Hiremath, MD, MPH, is a pediatric gastroenterologist leading the pediatric Eosinophilic Gastrointestinal Disorders clinic at Vanderbilt University. He is also a member of the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Dr. Hiremath’s research focuses on the epidemiology, pathogenesis, diagnosis, and management of eosinophilic gastrointestinal diseases (EGIDs). Here, he shares his start in rare disease research, exciting discoveries, and future goals. 

CEGIR Researchers Report on the FDA Workshop: Challenges, Progress, Questions in Eosinophilic Gastrointestinal Disorders jaquelyn.freie… Thu, 01/13/2022 - 08:24
Marc Rothenberg, MD, PhD, with a future researcher of eosinophilic disease
Marc Rothenberg, MD, PhD, with a future researcher of eosinophilic disease

The U.S. Food and Drug Administration (FDA) hosted a workshop on July 21, 2021 to discuss the disease characteristics, natural history, and endpoints to assess treatment benefit in patients with eosinophilic gastrointestinal disorders (EGID) beyond eosinophilic esophagitis (EoE). 

CEGIR’s Glenn Furuta Receives NASPGHAN 2021 Harry Shwachman Award Dakota Campbell Tue, 12/14/2021 - 10:54
Headshot of Glenn Furuta, MD

Glenn Furuta, MD, has received the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 2021 Harry Shwachman Award. Furuta was recognized during the 2021 NASPGHAN Annual Meeting on Monday, December 13.